期刊文献+

1p13.3rs599839单核苷酸多态性与早发冠状动脉粥样硬化性心脏病的关联研究 被引量:2

Association of single nucleotide polymorphism rs599839 on chromosome 1p13.3 with premature coronary heart disease in a Chinese Hart population
原文传递
导出
摘要 目的探讨中国汉族人群染色体1p13.3rs599839基因多态性与早发冠状动脉粥样硬化性心脏病(简称早发冠心病)的相关性。方法用聚合酶链反应一限制性片段长度多态性技术分析303例经冠状动脉冠脉造影确诊的早发冠心病患者rs599839基因多态性,以同期冠脉造影阴性、排除冠心病诊断的312名受试者为对照组,比较两组间rs599839基因多态性频率分布差异。结果早发冠心病组与对照组中均检出AA、AG基因型,GG基因型未检出。G等位基因频率在早发冠心病组和对照组中分别为5.0%、9.1%,差异有统计学意义(P=0.004),使用Logistic回归分析排除吸烟、高血压、糖尿病等因素的影响后,两组G等位基因频率差异仍有统计学意义(P〈0.05)。两组中G等位基因携带者(AG型)低密度脂蛋白胆固醇(low density lipoprotein-cholesterol,LDL-C)水平均低于AA纯合子。结论中国汉族人群染色体1p13.3rs599839基因多态性可能与早发冠心病发病相关;rs599839基因多态性可能与血清LDL-C浓度差异相关;rs599839基因多态性与冠脉狭窄程度无关。 Objective To investigate the association of single nucleotide polymorphism (SNP) rs599839 on chromosome lp13.3 with premature coronary heart disease. Methods A case-control association study of 303 unrelated premature coronary heart disease patients and 312 normal controls from a Chinese Han population was performed. Geno- type was determined by polymerase chain reaction-restriction fragment length polymorphism for SNP rs599839 on Chromo- some lp13.3. Result The frequencies of the G allele were 5.0% and 9.1% in the premature coronary heart disease group and control group respectively (P = 0.004). The presence of the G allele was associated with significantly lower concentration of the low density lipoprotein-cholesterol (LDL-C) in both groups. Conclusion The present findings sug- gest that the genetic polymorphism in IS599839 may be associated with the development of premature coronary heart disease in Chinese Han population, and the polymorphism may have some influence on serum LDL-C level in this population.
出处 《中华医学遗传学杂志》 CAS CSCD 北大核心 2008年第6期686-689,共4页 Chinese Journal of Medical Genetics
关键词 早发冠状动脉粥样硬化性心脏病 单核苷酸多态性 聚合酶链反应 低密度脂蛋白胆固醇 premature coronary heart disease single nucleotide polymorphism polymerase chain reaction low density lipoprotein-cholesterol
  • 相关文献

参考文献14

  • 1Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med, 2006,3 : e442.
  • 2Topoi EJ, Smith J, Plow EF, et al. Genetic susceptibility to myocardial infarction and coronary artery disease. Hum Mol Genet, 2006, 15 : R117- R123.
  • 3Wang Q. Molecular genetics of coronary artery disease. Curr Opin Cardiol,2005,20:182-188.
  • 4王晓玲,顾东风.冠心病遗传因素的研究进展[J].中华医学遗传学杂志,2000,17(6):452-454. 被引量:25
  • 5Abecasis G, Tam PK, Bustamante CD, et al. Human Genome Variation 2006:emerging views on structural variation and large-scale SNP analysis. Nat Genet, 2007,39:153-155.
  • 6Samani NJ, Erdmann J, Hall AS, et al. Genomewide association analysis of coronary artery disease. N Engl J Med, 2007,357:443-453.
  • 7Kathiresan S, Melander O, Guiducci C, et al. Six new loci associated with blood low-density lipoprotein cholesterol or triglycerides in humans. Nat Genet, 2008,40 : 189-197.
  • 8Willer CJ, Sanna S, Jackson AU, et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet, 2008,40:161-169.
  • 9Schadt EE, Molony C, Chudin E, et al. Mapping the genetic architecture of gene expression in human liver. PLOS Biol, 2008,6:e107.
  • 10Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol, 1983,51:606-606.

二级参考文献2

  • 1Cai H,Atherosclerosis,2000年,148卷,125页
  • 2Zhang H P,Ann Med,1997年,29卷,493页

共引文献24

同被引文献43

  • 1Wang Q. Molecular genetics of coronary artery disease[J]. Curr Opin Cardiol, 2005, 20(3) : 182-188.
  • 2Olson EN. Coronary artery disease and the MEF2A transcription factor[J]. Sci Aging Knowledge Environ, 2003,2003(48) : pe33.
  • 3Franehini M, Peyvandi F, Mannucci PM. The genetic basis of coronary artery disease: from candidate genes to whole genome analysis[J]. Trends Cardiovasc Med, 2008, 18(5) : 157-162.
  • 4Tr6gout DA, KSnig IR, Erdmann J, et al. G-enome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease[ J]. Nat Genet, 2009, 41(3) : 283-285.
  • 5Wang KI, Fan C, Topoi SE, et 81. Mutation of MEF2A in an inherited disorder with features of coronary arterydisease [ J J. Science, 2003, 302 ( 5650 ) : 1578-1581.
  • 6Bhagavatula MR, Fan C, Shen GQ, et al. Transcription factor MEF2A mutations in patients with coronary artery disease[J]. Hum Mol Genet, 2004, 13 (24) : 3181-3188.
  • 7Yuan H, Ltl HW, Hu J, et al. MEF2A gene and susceptibility to coronary artery disease in the Chinese People [ J ]. Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2006, 31(4) : 453-457.
  • 8Lieb W, Mayer B, Kfinig IR, et al. Lack of association between the MEF2A gene and myocardial infarction[J]. Circulation, 2008, 117(2) : 185-191.
  • 9Altshuler D, Hirschhom JN. MEF2A sequence variants and coronary artery disease: a ehange of heart[J] 9 J Clin Invest, 2005, 115(4) : 831-833.
  • 10Helgadottir A, Manoleseu A, Thorleifsson G, et al. The gene encoding 5-1i-poxygenase activating protein confers risk of myocardial infarction and stroke [J]. Nat Genet, 2004, 36(3) : 233-239.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部